{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:44:40Z","timestamp":1790113480976,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1053\/j.ajkd.2023.08.021","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:28:41Z","timestamp":1697776121000},"page":"489-496.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity"],"prefix":"10.1053","volume":"83","author":[{"given":"Debbie C.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H.","family":"Ix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly J.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidra C.","family":"Crews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Bullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titilayo","family":"Ilori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav S.","family":"Garimella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8902-9576","authenticated-orcid":false,"given":"Michelle M.","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1053\/j.ajkd.2023.08.021_bib1","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1681\/ASN.2021070988","article-title":"A\u00a0unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease","volume":"32","author":"Delgado","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"20","key":"10.1053\/j.ajkd.2023.08.021_bib2","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1053\/j.ajkd.2023.08.021_bib3","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1053\/j.ajkd.2023.08.021_bib4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2011.468","article-title":"Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality","volume":"305","author":"Peralta","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.021_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1681\/ASN.2010050483","article-title":"Cystatin C identifies chronic kidney disease patients at higher risk for complications","volume":"22","author":"Peralta","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.021_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-147-1-200707030-00004","article-title":"Cystatin C as a risk factor for outcomes in chronic kidney disease","volume":"147","author":"Menon","year":"2007","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1053\/j.ajkd.2023.08.021_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-142-7-200504050-00008","article-title":"Cystatin C concentration as a risk factor for heart failure in older adults","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1053\/j.ajkd.2023.08.021_bib8","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41591-019-0627-8","article-title":"Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease","volume":"25","author":"Lees","year":"2019","journal-title":"Nat Med"},{"issue":"6","key":"10.1053\/j.ajkd.2023.08.021_bib9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2008.638","article-title":"Factors other than glomerular filtration rate affect serum cystatin C levels","volume":"75","author":"Stevens","year":"2009","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2023.08.021_bib10","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","article-title":"Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement","volume":"65","author":"Knight","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2023.08.021_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.amjmed.2008.01.003","article-title":"Overweight, obesity, and elevated serum cystatin C levels in adults in the United States","volume":"121","author":"Muntner","year":"2008","journal-title":"Am J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2023.08.021_bib12","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2023.08.021_bib13","series-title":"National Health and Nutrition Examination Survey 2017\u2013March 2020 prepandemic data files development of files and prevalence estimates for selected health outcomes. National Health Statistics Reports no. 158","author":"Stierman","year":"2021"},{"key":"10.1053\/j.ajkd.2023.08.021_bib14","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.021_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2023.08.021_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000086678","article-title":"The reasons for geographic and racial differences in stroke study: objectives and design","volume":"25","author":"Howard","year":"2005","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.021_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365519950185940","article-title":"Evaluation of the Dade Behring N latex cystatin C assay on the Dade Behring nephelometer II system","volume":"59","author":"Erlandsen","year":"1999","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2023.08.021_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.ajkd.2008.05.004","article-title":"Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study","volume":"52","author":"Kurella Tamura","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.021_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1053\/j.ajkd.2023.08.021_bib20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1 suppl 1","key":"10.1053\/j.ajkd.2023.08.021_bib21","first-page":"S1","article-title":"US Renal Data System 2019 annual data report: epidemiology of kidney disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"20","key":"10.1053\/j.ajkd.2023.08.021_bib22","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.CIR.0000100560.46946.EA","article-title":"Case definitions for acute coronary heart disease in epidemiology and clinical research studies","volume":"108","author":"Luepker","year":"2003","journal-title":"Circulation"},{"issue":"20","key":"10.1053\/j.ajkd.2023.08.021_bib23","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"issue":"16","key":"10.1053\/j.ajkd.2023.08.021_bib24","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"issue":"14","key":"10.1053\/j.ajkd.2023.08.021_bib25","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.2020.1267","article-title":"Why test for proportional hazards?","volume":"323","author":"Stensrud","year":"2020","journal-title":"JAMA"},{"issue":"19","key":"10.1053\/j.ajkd.2023.08.021_bib26","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJMoa2103753","article-title":"Race, genetic ancestry, and estimating kidney function in CKD","volume":"385","author":"Hsu","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2023.08.021_bib27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1751-7176.2011.00548.x","article-title":"Relationship between body mass index and high cystatin levels among US adults","volume":"13","author":"Shankar","year":"2011","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"12","key":"10.1053\/j.ajkd.2023.08.021_bib28","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/oby.2009.96","article-title":"Potential contribution of adipose tissue to elevated serum cystatin C in human obesity","volume":"17","author":"Naour","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"10.1053\/j.ajkd.2023.08.021_bib29","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1096\/fj.05-3673fje","article-title":"Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis","volume":"19","author":"Taleb","year":"2005","journal-title":"FASEB J"},{"issue":"6","key":"10.1053\/j.ajkd.2023.08.021_bib31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ki.2013.7","article-title":"Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease","volume":"83","author":"Rule","year":"2013","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2023.08.021_bib32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1681\/ASN.2010050479","article-title":"Estimated GFR associates with cardiovascular risk factors independently of measured GFR","volume":"22","author":"Mathisen","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623008818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623008818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:51:17Z","timestamp":1759463477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623008818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0272638623008818"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.08.021","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}]}}